RA Capital Management »

Nuvalent Inc-a shares owned by RA Capital Management

Quarter-by-quarter ownership of Nuvalent Inc-a (NUVL) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Nuvalent Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Nuvalent Inc-a held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvalent Inc-a by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $18M 176k 102.30
2024-06-30 $9.1M 120k 75.86

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)
Biogen SH (BIIB)
Dyne Therapeutics SH (DYN)
Rxsight SH (RXST)
Bicara Therapeutics SH
Climb Bio SH (ELYM)
Ars Pharmaceuticals SH (SPRY)

View all positions for RA Capital Management

Top funds holding Nuvalent Inc-a

Deerfield Management Company
Paradigm Biocapital Advisors
Vanguard Group
BlackRock
BlackRock
Perceptive Advisors
Bain Capital Life Sciences Investors
Fairmount Funds Management
State Street Corporation
Woodline Partners
Boxer Capital
T. Rowe Price Associates
Commodore Capital
Driehaus Capital Management
Geode Capital Management

View all funds holding Nuvalent Inc-a